Dr Reddy’s recalls over 8,000 bottles of generic drug in US due to packaging error
时间:2024-06-26 13:54:50 阅读(143)
Dr Reddy’s Laboratories is recalling over 8,000 bottles of a generic medication used to prevent rejection of a transplanted organ from the US market due to a packaging error, according to the US Food & Drug Administration.
The Hyderabad-based drug major is recalling 8,280 bottles of Tacrolimus capsules from the US market for “presence of foreign tablets/capsules” in the affected lot.
The affected lot was produced at Dr Reddy’s Bachupally-based plant near Hyderabad.
New Jersey-based Dr Reddy’s Laboratories, Inc has initiated the nationwide (US) Class II recall on December 15, 2023.
As per the USFDA, a Class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Dr Reddy’s had recalled 4,000 bottles of the same drug in March last year as well. The company had initiated the recall on February 8, 2023.
猜你喜欢
- Troo Good assigns advertising and communication duties to Wunderman Thompson
- To fight malaria, Agartala municipality releases larvae-eating fishes into rivers, lakes
- Namo Bharat on Track- NCRTC begins trial run on Duhai-Meerut stretch of RRTS Corridor! Cutting-edge testing underway – All you need to know
- Sensex, Nifty open in red on Tuesday, Jan 3; HFCL shares rise over 2%, Zomato shares fall 2%
- MPhil is not recognised degree, UGC says in new alert! Here are fresh guidelines for next academic session
- Techno Electric & Engineering Company gets smart metering and transmission projects worth Rs 1,750 crore
- NCLT adjourns Future Retail case, pushes it to January 4
- Tridhya Tech to hit capital market on Friday with IPO to raise up to Rs 26
- Navigating Finances Together- Tips to effectively manage money as a couple